Liver Transplantation

Liver Transplantation at Baylor:
Disease-Specific Results and Long-Term Outcomes

Robert M. Goldstein

Table 5. Percent survival in hepatitis B surface antigen-positive patients with reference to e-antigen status

Survival	HBsAg+ n=50	HBeAg- n=21	HBeAg+ n=22	Other** n=691
1 yr	71.6	75.3	58.7	84.1
2 yr*	53.2	52.8	42.7	79.5
3 yr*	40.9	45.3	36.6	76.2
4 yr*	36.3	45.3	36.6	74.0

* P<0.05 HBsAg+ versus "other" group
** Patients with non-hepatitis liver disease

Go to top · Return to Chapter · Return to Table of Contents

Please be aware that medical advice, diagnoses and physician references cannot be obtained from this site.